Trial
NCT04809623
Study of Edecesertib in Participants With Cutaneous Lupus Erythematosus (CLE)
Phase ITERMINATEDOPERATIONALConfidence: HIGH
Sponsor
Gilead Sciences
Collaborators
—
Condition
Cutaneous Lupus Erythematosus
Intervention
Edecesertib
Why stopped
Sponsor decision to terminate study.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2024-04-05